Research programme: glucagon-like peptide-2 analogues - Theratechnologies
Alternative Names: TH 0312Latest Information Update: 19 Mar 2008
At a glance
- Originator Theratechnologies
- Class Peptides
- Mechanism of Action Glucagon-like peptide 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases